Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach

Cardiology: Heart Failure Medication Reduces Heart Size The new wonder drug in heart failure management, Sacubitril/Valsartan, rejuvenates the heart by preventing its dilation. Using data from myocardial infarction and heart failure samples, we generated a mathematical model to better understand how...

Full description

Bibliographic Details
Main Authors:	Oriol Iborra-Egea, Carolina Gálvez-Montón, Santiago Roura, Isaac Perea-Gil, Cristina Prat-Vidal, Carolina Soler-Botija, Antoni Bayes-Genis
Format:	Article
Language:	English
Published:	Nature Publishing Group 2017-04-01
Series:	npj Systems Biology and Applications
Online Access:	https://doi.org/10.1038/s41540-017-0013-4

Similar Items

Epigenetic Biomarkers in Cardiovascular Diseases
by: Carolina Soler-Botija, et al.
Published: (2019-10-01)

Data on effect of Sacubitril/valsartan on cardiac Remodelling in diabetic Cardiomyopathy rats
by: Jiao Ai, et al.
Published: (2021-04-01)

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
by: Pema Raj, et al.
Published: (2021-08-01)

Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing
by: Isaac Perea-Gil, et al.
Published: (2018-04-01)

Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
by: Mi‐Gil Moon, et al.
Published: (2021-06-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
by: Josep Lupón, et al.
Published: (2021-01-01)

Preclinical Evaluation of the Immunomodulatory Properties of Cardiac Adipose Tissue Progenitor Cells Using Umbilical Cord Blood Mesenchymal Stem Cells: A Direct Comparative Study
by: Isaac Perea-Gil, et al.
Published: (2015-01-01)

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
by: Santiago Roura, et al.
Published: (2017-10-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
by: Ulrik Ø Andersen, et al.
Published: (2020-05-01)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
by: Luís Beck-da-Silva, et al.

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018-08-01)

A narrative review on sacubitril/valsartan and ventricular arrhythmias
by: Gao, M., et al.
Published: (2022)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
by: Giuseppe Vergaro, et al.
Published: (2021-02-01)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes
by: Rafael de laEspriella, et al.
Published: (2020-12-01)

Impact of Umbilical Cord Blood-Derived Mesenchymal Stem Cells on Cardiovascular Research
by: Santiago Roura, et al.
Published: (2015-01-01)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
by: Einar Sjaastad Nordén, et al.
Published: (2021-04-01)

Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo.
by: Santiago Roura, et al.
Published: (2012-01-01)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
by: Hyue-Mee Kim, et al.
Published: (2021-04-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
by: Jelena P. Seferovic, et al.
Published: (2020-12-01)

Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
by: António Valentim Gonçalves, et al.
Published: (2019-06-01)

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
by: Carlos Escobar, et al.
Published: (2019-12-01)

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
by: Borja Quiroga, et al.
Published: (2019-11-01)

Sacubitril-valsartan in the real world: From theory to clinical practice
by: Ricardo Fontes-Carvalho
Published: (2018-06-01)

Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
by: Ramesh R. Dargad, et al.
Published: (2018-07-01)

Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure
by: Pedro Marques da Silva, et al.
Published: (2017-09-01)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
by: Prashanth Rawla, et al.
Published: (2019-05-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

12. Sacubitril/valsartan in the treatment of systemic right ventricular failure
by: Marieke Nederend, et al.
Published: (2021-02-01)

Renal protective effect of sacubitril/valsartan in patients with heart failure
by: Hui-Ling Hsieh, et al.
Published: (2021-02-01)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
by: Paloma Gastelurrutia, et al.
Published: (2021-02-01)

Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
by: Marta Monguió-Tortajada, et al.
Published: (2017-11-01)

Effect of sacubitril/valsartan on the expression of Gal-3 and MMP-9 in rabbits with cardiac hypertrophy
by: Song-Chen Jiang, et al.
Published: (2019-04-01)

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
by: Egle Corrado, et al.
Published: (2020-08-01)